UNSW Sydney


UNSW Sydney (The University of New South Wales) is one of Australia's leading research and teaching universities, ranked among the top 50 universities in the world1.

UNSW is known for producing innovative, pioneering research that has a global impact, attracting some of the most talented researchers and research students worldwide. Our partnerships with industry, international organisations, governments and other leading universities worldwide make us an attractive option for research investors.

Among many achievements, UNSW has pioneered the global development of solar energy technologies, helped to control devastating epidemics such as HIV, developed new therapies for depression and anxiety, and made previously unimaginable breakthroughs in quantum computing.

With more than 50,000 students from over 120 countries, UNSW is one of Australia’s most diverse and cosmopolitan universities.

UNSW is a founding member of the Group of Eight, a coalition of Australia’s leading research intensive universities, and a member of the prestigious Universitas 21 international network, Global Tech Alliance, Association of Pacific Rim Universities and Sydney Partnership for Health, Education, Research and Enterprise.

With King’s College London and Arizona State University Phoenix, UNSW Sydney is also a founding member of the PLuS Alliance, which creates, enables and deploys innovative research and education linkages to develop sustainable solutions to society’s global challenges. The PLuS Alliance provides cross-institutional programmes for students around the globe, establishes research connections across the universities, and contributes to a sustainable future by collaborating in the areas of global health, social justice, technology and innovation.

The main UNSW campus is located on a 38-hectare site at Kensington, seven kilometres from the centre of Sydney. Other major campuses are UNSW Art & Design in the Sydney suburb of Paddington, and UNSW Canberra at the Australian Defence Force Academy.

UNSW has eight faculties - Art and Design, Arts and Social Sciences, Built Environment, UNSW Business School, Engineering, Law, Medicine, Science and UNSW Canberra at ADFA; offering an extensive range of undergraduate, postgraduate and research programs.

1 2017 QS World University Rankings

UNSW Sydney retains sole responsibility for content © 2017 UNSW Sydney.

1 December 2017 - 30 November 2018

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for University of New South Wales (UNSW) published between 1 December 2017 - 30 November 2018 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

382 116.66

Outputs by subject (FC)

Subject AC FC
Life Sciences 120 27.36
Physical Sciences 105 28.10
Earth & Environmental Sciences 93 30.13
Chemistry 107 43.36

Highlight of the month

A ‘natural’ gene therapy for blood disorders

© Narupon Promvichai/EyeEm/Getty

© Narupon Promvichai/EyeEm/Getty

By reproducing naturally occurring mutations that elevate the production of foetal haemoglobin, a new CRISPR-based gene therapy could help treat inherited blood disorders such as sickle cell disease and β-thalassemia.

The mutations are found in patients with a benign condition called ‘hereditary persistence of foetal haemoglobin’, or HPFH, in which the γ-globin that is normally switched off after birth remains active.

A team led by scientists at the University of New South Wales identified two repressor proteins that normally bind part of the γ-globin gene at specific sites where mutations responsible for HPFH occur.

Using CRISPR gene-editing technology, they introduced HPFH-associated mutations into blood-forming cells and saw elevated expression of the γ-globin gene.

This finding helps clarify how these mutations prevent gene silencing, and it highlights a potential way to reactivate foetal haemoglobin production using genetic changes known to be safe in people.

Supported content

  1. Nature Genetics 50, 498–503 (2018). doi: 10.1038/s41588-018-0085-0

View the article on the Nature Index

See more research highlights from UNSW Sydney

More research highlights from UNSW Sydney

1 December 2017 - 30 November 2018

International vs. domestic collaboration by FC

  • 33.71% Domestic
  • 66.29% International

Note: Hover over the graph to view the percentage of collaboration.

Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.

Affiliated joint institutions and consortia

Return to institution outputs